| 穆金兴,陈要起,齐丽平,等.经皮冠状动脉介入治疗急性心肌梗死手术期使用比伐卢定的安全性和有效性分析[J].安徽医药,2019,23(1):158-160. |
| 经皮冠状动脉介入治疗急性心肌梗死手术期使用比伐卢定的安全性和有效性分析 |
| Safety and efficacy of bivalirudin in patients with acute myocardial infarction undergoing percutaneous coronary intervention |
| 投稿时间：2017-06-28 |
| DOI： |
| 中文关键词: 心肌梗死 血管成形术,气囊,冠状动脉 支架 肝素 比伐卢定 |
| 英文关键词: Myocardial infarction Angioplasty,balloon,coronary Stents Heparin Bivalirudin |
| 基金项目: |
|
| 摘要点击次数: 1838 |
| 全文下载次数: 585 |
| 中文摘要: |
| 目的 探讨对经皮冠状动脉介入治疗急性心肌梗死手术期使用比伐卢定的安全性和有效性。方法 收集邢台市第三医院2014年1月至2016年6月的急性心肌梗死(AMI)拟行经皮冠状动脉介入(PCI)的病人217例为研究对象,随机数字表法分为观察组(比伐卢定组)和对照组(肝素组),统计分析其安全性和有效性。结果 观察组病死率4例(4.30%)明显低于对照组17例(13.71%)(χ2=4.452, P=0.020)；观察组的主要心脏不良事件发生率、大出血发生率、输血发生率、血小板减少发生率均明显低于对照组,差异有统计学意义(P<0.05)；但支架内血栓发生率两组差异无统计学意义(P>0.05)。结论 与肝素相比,AMI病人行PCI手术期使用比伐卢定,能够获得更好的抗凝疗效,并且还能显著减少血小板减少发生率,具有相对较好的安全性和抗栓疗效。 |
| 英文摘要: |
| Objective To investigate the safety and efficacy of Bivalirudin in patients with acute myocardial infarction (AMI) undergoing percutaneous coronary intervention (PCI).Methods 217 cases of AMI patients treated in Xingtai Third Hospital from January 2014 to June 2016 were selected and divided into the observation group (bivalirudin group) and the control group (heparin group) according to the random table method.Then the safety and efficacy of two groups were compared through statistical analysis.Results The incidence of major adverse cardiac events,mortality,major bleeding rate,blood transfusion rate was lower in the control group than that of control group (P<0.05).Furthermore,the control group had a significantly higher incidence rate of thrombocytopenia than that of the observation group [4(4.30%) vs. 17(13.71%),χ2=4.452, P=0.020],while no statistic difference was found in the incidence rate of stent thrombosis (P>0.05).Conclusions Compared with the application of heparin,Bivalirudin has relatively good safety and antithrombotic effect for AMI patients undergoing PCI,which can also significantly reduce the incidence of thrombocytopenia. |
|
查看全文
查看/发表评论 下载PDF阅读器 |
| 关闭 |
|
|
|
